FDA, AMA, Others Back New Healthcare Notification Network


By Neil Versel 

March 25, 2008 | A coalition of medical societies, malpractice insurers, pharmaceutical and medical device manufacturers, health plans, and government agencies is trying to end the era of paper patient-safety alerts with the launch of an electronic network to disseminate wide-scale drug and device recalls and warnings.

“We’re talking about moving patient safety online and out of the U.S. Mail,” says Nancy Dickey, M.D., chair of the iHealth Alliance and past president of the American Medical Association. The iHealth Alliance is the governing body of the Medem network, a physician connectivity service founded by national medical societies that is providing the technology to the new Health Care Notification Network (HCNN).

The Health Care Notification Network, publicly unveiled Tuesday morning, is intended to speed up—and ultimately replace—the long-standing process of mailing drug and device warnings and recalls to healthcare providers. “This way, doctors … won’t be hearing of problems first from the media or patients who come into their office, so they won’t be blindsided,” according to Janet Woodcock, M.D., chief medical officer and director of the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).

The FDA has indicated a preference for e-mail and other electronic forms of communication for disseminating information to the public. The agency has agreed to participate in the HCNN.

Dickey, who also is president of the Texas A&M Health Science Center (College Station, Texas), calls the network a “single, simple organized source for all product-related safety information.”

In addition to speeding up the notification process, the site adds “interactive bells and whistles” to help deliver “more robust information” to clinicians and their patients, according to Medem chief executive Edward Fotsch, M.D.

A typical HCNN screen contains the actual alert in the center column, formatted with the same fonts and colors the FDA recommends for mailed notifications. The left-hand column has links for more information on the drug or device in questions—including images—as well as a link for the user to contact the manufacturer. The right side of the screen has suggestions on how care providers can notify patients, plus a link to the FDA MedWatch reporting program.

Doctors who have Web portals through Medem can send the alerts to their sites and e-mail the information directly to patients with iHealthRecords, Medem’s personal health record (PHR) product, Fotsch says.

Alerts will be tailored to specialties so physicians are not overwhelmed with every notice for every device or drug. “Nothing will make people discard information faster than receiving a large number of irrelevant alerts,” Dickey says.

There is no charge for healthcare providers to participate. “If you can get patient safety today on a free network, you’re hard-pressed to wait two weeks [for a manufacturer to print and mail a paper alert],” Fotsch says.

Malpractice insurance carriers, through the Physician Insurance Association of America (PIAA), are supporting HCNN as an essential element of patient safety, and the Joint Commission has endorsed the effort. “I am asking our insured physicians to enroll in the HCNN and receive their FDA-related patient safety notifications online,” says David Troxel, M.D., medical director of malpractice insurer The Doctors Co.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .